92 related articles for article (PubMed ID: 8649819)
1. Identification and cloning of EI24, a gene induced by p53 in etoposide-treated cells.
Lehar SM; Nacht M; Jacks T; Vater CA; Chittenden T; Guild BC
Oncogene; 1996 Mar; 12(6):1181-7. PubMed ID: 8649819
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of genes whose expressions are altered in rat 6 fibroblasts transformed by mutant p53(val135).
Yam JW; Zheng JY; Hsiao WL
Biochem Biophys Res Commun; 1999 Dec; 266(2):472-80. PubMed ID: 10600527
[TBL] [Abstract][Full Text] [Related]
3. An analysis of an interactome for apoptosis factor, Ei24/PIG8, using the inducible expression system and shotgun proteomics.
Bahk YY; Lee J; Cho IH; Lee HW
J Proteome Res; 2010 Oct; 9(10):5270-83. PubMed ID: 20731388
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras.
Fenton RG; Hixon JA; Wright PW; Brooks AD; Sayers TJ
Cancer Res; 1998 Aug; 58(15):3391-400. PubMed ID: 9699671
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a human MSX-2 cDNA and its fragment isolated as a transformation suppressor gene against v-Ki-ras oncogene.
Takahashi C; Akiyama N; Matsuzaki T; Takai S; Kitayama H; Noda M
Oncogene; 1996 May; 12(10):2137-46. PubMed ID: 8668339
[TBL] [Abstract][Full Text] [Related]
6. Isolation of canine p53 cDNA and detailed characterization of the full length canine p53 protein.
Veldhoen N; Milner J
Oncogene; 1998 Feb; 16(8):1077-84. PubMed ID: 9519881
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of murine vav2, a member of the vav family of proto-oncogenes.
Schuebel KE; Bustelo XR; Nielsen DA; Song BJ; Barbacid M; Goldman D; Lee IJ
Oncogene; 1996 Jul; 13(2):363-71. PubMed ID: 8710375
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of hypoxia on etoposide-induced apoptosis according to the cancer cell lines.
Cosse JP; Sermeus A; Vannuvel K; Ninane N; Raes M; Michiels C
Mol Cancer; 2007 Sep; 6():61. PubMed ID: 17894897
[TBL] [Abstract][Full Text] [Related]
9. Cloning and characterization of a novel gene PDRG that is differentially regulated by p53 and ultraviolet radiation.
Luo X; Huang Y; Sheikh MS
Oncogene; 2003 Oct; 22(46):7247-57. PubMed ID: 14562055
[TBL] [Abstract][Full Text] [Related]
10. Csa-19, a radiation-responsive human gene, identified by an unbiased two-gel cDNA library screening method in human cancer cells.
Balcer-Kubiczek EK; Meltzer SJ; Han LH; Zhang XF; Shi ZM; Harrison GH; Abraham JM
Oncogene; 1997 Jun; 14(25):3051-7. PubMed ID: 9223668
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning of the bovine alpha 1(IV) procollagen gene (COL4A1) and its use in investigating the regulation of expression of type IV procollagen by retinoic acid in bovine lens epithelial cells.
Sawhney RS; Wood LS; Vogeli G
Cell Biol Int; 1997 Aug; 21(8):501-10. PubMed ID: 9451807
[TBL] [Abstract][Full Text] [Related]
12. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
[TBL] [Abstract][Full Text] [Related]
13. Complete nucleotide and deduced amino acid sequences of human and murine preprocathepsin L. An abundant transcript induced by transformation of fibroblasts.
Joseph LJ; Chang LC; Stamenkovich D; Sukhatme VP
J Clin Invest; 1988 May; 81(5):1621-9. PubMed ID: 2835398
[TBL] [Abstract][Full Text] [Related]
14. Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function.
Kuo ML; Chou YW; Chau YP; Huang TS
Mol Carcinog; 1997 Apr; 18(4):221-31. PubMed ID: 9142217
[TBL] [Abstract][Full Text] [Related]
15. The product of the cph oncogene is a truncated, nucleotide-binding protein that enhances cellular survival to stress.
Velasco JA; Avila MA; Notario V
Oncogene; 1999 Jan; 18(3):689-701. PubMed ID: 9989819
[TBL] [Abstract][Full Text] [Related]
16. Mutant K-ras enhances apoptosis in embryonic stem cells in combination with DNA damage and is associated with increased levels of p19(ARF).
Brooks DG; James RM; Patek CE; Williamson J; Arends MJ
Oncogene; 2001 Apr; 20(17):2144-52. PubMed ID: 11360198
[TBL] [Abstract][Full Text] [Related]
17. Carboxypeptidase A3 (CPA3): a novel gene highly induced by histone deacetylase inhibitors during differentiation of prostate epithelial cancer cells.
Huang H; Reed CP; Zhang JS; Shridhar V; Wang L; Smith DI
Cancer Res; 1999 Jun; 59(12):2981-8. PubMed ID: 10383164
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression.
Liu XL; Wazer DE; Watanabe K; Band V
Cancer Res; 1996 Jul; 56(14):3371-9. PubMed ID: 8764136
[TBL] [Abstract][Full Text] [Related]
19. Distinct p53-mediated G1/S checkpoint responses in two NIH3T3 subclone cells following treatment with DNA-damaging agents.
Huang TS; Kuo ML; Shew JY; Chou YW; Yang WK
Oncogene; 1996 Aug; 13(3):625-32. PubMed ID: 8760304
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis factor EI24/PIG8 is a novel endoplasmic reticulum-localized Bcl-2-binding protein which is associated with suppression of breast cancer invasiveness.
Zhao X; Ayer RE; Davis SL; Ames SJ; Florence B; Torchinsky C; Liou JS; Shen L; Spanjaard RA
Cancer Res; 2005 Mar; 65(6):2125-9. PubMed ID: 15781622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
